Taken together, these data demonstrate that CRISPR/Cas 9-mediated deletion of GLO1 does not impact proliferative capacity while causing significant sensitization to methylglyoxal-, chemotherapy-, and starvation-induced cytotoxic stress in A375 malignant melanoma cells. The gene discussed is GLO1; the disease is melanoma.